No Data
No Data
GSK Gets Expanded EU Approval for Jemperli in Endometrial Cancer
Express News | Maison Solutions Shares Halted; Last up 30.8% at $1.70
Express News | Reported Earlier, Maison Solutions Q2 EPS $(0.01) Down From $0.01 YoY, Sales $31.02M Up From $13.77M YoY
Maison Solutions Reports Second Quarter and Six-Month 2025 Financial Results
Maison Solutions Backs FY25 Rev Guidance of $120M-$125M
Maison Solutions | 8-K: Maison Solutions Reports Second Quarter and Six-Month 2025 Financial Results
小强不死 : I ran 1.94, thank you.@Trytosaveabit
Trytosaveabit OP 小强不死 : Nicely done! Congrats on a great trade! You’re welcome!